We thank d'Annunzio, Russo, and Lorini (1) for their interest in our article (2) related to carbohydrate-insulin variables in youth and later adult pre-diabetes and diabetes. As they noted, normal values of homeostasis model assessment of insulin resistance (HOMA-IR) are increased with sexual maturation. This is consistent with our previous findings in Bogalusa, Louisiana, with children. Svec et al. (3) reported earlier that there was a positive trend of postglucose insulin response with increasing Tanner stages.
The study cohort from our population emphasized the usefulness and the need to develop common cut-off values of childhood glucose homeostasis variables for predicting adult pre-diabetes and type 2 diabetes. Whether the risk of developing type 2 diabetes is best determined by fasting plasma glucose (FPG), insulin, or HOMA-IR remains unclear. The FPG level has been proven to have high reproducibility, small variability, and favorable application to clinical settings (4). In a multivariate analysis of repeated measurements (generalized equation estimation method) adjusted for traditional risk factors, we demonstrated that childhood FPG, more so than insulin, is a critical and independent predictor of adult pre-diabetes and type 2 diabetes 21 years later (5).
Earlier Bergman (6) questioned the adequacies of absolute threshold levels for diagnosing pre-diabetes. Indeed, the current cut-off value of FPG (100 mg/dl), revised by the American Diabetes Association (ADA), is applied without distinction of age-group even in youth. Moreover, the ADA asserted that risk for diabetes related to FPG is continuous. However, our other findings indicated a threshold of 85 mg/dl in children, above which the risk of adult diabetes began to increase (7).
In view of the prevalence of type 2 diabetes in epidemic proportions, there is an urgent need to address the issue of establishing an appropriate FPG cut-off point in children for predicting diabetes status later in life.
Acknowledgments
This research was supported by grants AG16592 from the National Institute on Aging and 0855082E from the American Heart Association.